Stereotaxis Inc
AMEX:STXS
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.715
2.35
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one STXS stock under the Base Case scenario is 1.4 USD. Compared to the current market price of 1.94 USD, Stereotaxis Inc is Overvalued by 28%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Stereotaxis Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for STXS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Stereotaxis Inc
Balance Sheet Decomposition
Stereotaxis Inc
Current Assets | 28.1m |
Cash & Short-Term Investments | 14.7m |
Receivables | 2.8m |
Other Current Assets | 10.6m |
Non-Current Assets | 7.9m |
PP&E | 7.8m |
Other Non-Current Assets | 116k |
Current Liabilities | 12.3m |
Accounts Payable | 4.1m |
Accrued Liabilities | 2.1m |
Other Current Liabilities | 6m |
Non-Current Liabilities | 7m |
Other Non-Current Liabilities | 7m |
Earnings Waterfall
Stereotaxis Inc
Revenue
|
23.7m
USD
|
Cost of Revenue
|
-9.7m
USD
|
Gross Profit
|
14.1m
USD
|
Operating Expenses
|
-35.8m
USD
|
Operating Income
|
-21.7m
USD
|
Other Expenses
|
-374k
USD
|
Net Income
|
-22.1m
USD
|
Free Cash Flow Analysis
Stereotaxis Inc
USD | |
Free Cash Flow | USD |
In the second quarter of 2024, Stereotaxis reported revenue of $4.5 million, a decline from $7.9 million last year, primarily due to delays in system deliveries. The backlog stood at $15.3 million, and the gross margin was 74%. Looking forward, the company anticipates over $14 million in revenue for the second half of the year. It aims to consolidate results from its recent APT acquisition from August. The anticipated launch of GenesisX and a proprietary catheter, MAGiC, are expected to significantly improve revenue per procedure, enhancing Stereotaxis's growth outlook.
What is Earnings Call?
STXS Profitability Score
Profitability Due Diligence
Stereotaxis Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
Stereotaxis Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
STXS Solvency Score
Solvency Due Diligence
Stereotaxis Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
Stereotaxis Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STXS Price Targets Summary
Stereotaxis Inc
According to Wall Street analysts, the average 1-year price target for STXS is 4.59 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD.
Dividends
Current shareholder yield for STXS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
STXS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 130 full-time employees. The company went IPO on 2004-08-12. The firm's robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The firm also offers to its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto an integrated display, enabling physicians to view and control all the key information in the operating room.
Contact
IPO
Employees
Officers
The intrinsic value of one STXS stock under the Base Case scenario is 1.4 USD.
Compared to the current market price of 1.94 USD, Stereotaxis Inc is Overvalued by 28%.